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RNA recognition motifTelomeres are dynamic DNA–protein complexes that protect the ends of linear chromosome. Telomere-binding
proteins play crucial role in themaintenance of telomeres. HnRNPA3hasbeen shown recently tobind speciﬁcally
to single-stranded telomeric DNA in vitro, although its in vivo telomere function remains unknown. In this study,
the DNA-binding properties of hnRNPA3 in vitro aswell as its putative role of telomeremaintenance in vivowere
investigated. The minimal sequence for hnRNP A3 binding to DNA was determined as an undecamer with the
following consensus sequence 5′-[T/C]AG[G/T]NN[T/C]AG[G/T]N-3′. Confocal microscopy and chromatin-
immunoprecipitation (ChIP) analyses showed that hnRNPA3 is associatedwith telomere in vivo. Knocking-down
the expression of hnRNP A3 had no effect on telomere lengthmaintenance and did not affect cell proliferation. In
contrast, overexpression of hnRNP A3 resulted in the production of steady-state short telomeres in OECM1 cells.
These results suggest that hnRNP A3 is associated with telomere in vivo and acts as a negative regulator of
telomere length maintenance.RNA; hnRNP, heterogeneous
; ChIP, chromatin immunopre-
y; TRF, telomeric restriction
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Telomeres are specialized structures that protect the ends of linear
chromosomes [1,2]. Human telomeres contain repeats of sequence
CCCTAA/TTAGGG that vary from 2 to 50 kilobase pairs and a short
single-stranded G-rich 3′-overhang. The DNA is tightly associated
with a complex of six telomere-speciﬁc proteins, named shelterin, as
well as with surrounding chromatin regulatory factors [3–5]. Recent
studies have identiﬁed telomeric repeat-containing RNA (TERRA) as
an integral component of telomeric heterochromatin, which may be
involved in cis-based mechanisms of telomeric chromatin organiza-
tion and maintenance [6,7]. Dynamic changes in telomere length and
structure play key role in cellular division, replicative senescence, and
genome stability [8,9]. Telomere attrition represents a normal
mechanism that limits the replicative potential of human somatic
cells and can serve as a tumor suppressor pathway for potential cancer
cells. The gradual loss of telomeric DNA with each round of DNA
replication depletes the telomere reserve and leads to a growth arrest
that is accompanied by senescence or apoptosis, a process known as
replicative senescence.The most versatile and widely used method of telomere length
maintenance is based on telomerase. Human telomerase is a specialized
ribonucleoprotein polymerase that directs the synthesis of telomeric
repeats at 3′ ends of the G-rich strand [10]. Telomerase is repressed in
normal human somatic cells. These cells undergo telomere attrition and
have a limited proliferation capacity. In contrast, a majority of immortal
and cancer cells have an indeﬁnite proliferation capacity and maintain
their telomere length by upregulating telomerase [11,12]. While the
regulated telomerase expression may serve as the primary control of
telomere length maintenance, the synthesis of telomeric DNA by
telomerase is anticipated to be affected by many factors such as the
heterochromatin status of telomere, the recruitment of telomerase to
the telomere terminus, the initiation of elongation, and/or the
processivity of the elongation cycles. Therefore, telomere length is
inﬂuenced by the level of telomerase expression but also depends on
control pathways that act on recruitment of telomerase and/or in cis at
each individual telomere [13]. Indeed, telomere-binding proteins and
telomerase-interacting proteins have been demonstrated to participate
in telomere length homeostasis [10,14].
Heterogeneous nuclear ribonucleoproteins (hnRNPs) constitute a
large family of proteins that associate with nascent pre-mRNAs,
packaging them into hnRNP particles [15,16]. In addition to their action
as RNA-binding proteins, several members of the hnRNP family are
thought to play roles in telomere maintenance as DNA-binding or
telomerase-interacting proteins [14,17,18]. For examples, hnRNPs A1,
C1/C2, D are capable of interacting with the human telomerase holo-
enzyme, and hnRNPs A1, A2/B1, A3, D, and E are known to associate
with the single-stranded telomeric repeat sequence of DNA in vitro [19–
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telomere length regulation in vivo [29,30].
HnRNP A3 is one of the recently identiﬁed telomere-binding
protein that inhibits telomerase and protect telomeric repeats in vitro
[20,31]. Compared to the other members of hnRNP A/B family such as
A1 and A2/B1, relatively little is known about the functions of hnRNP
A3. HnRNP A3 has been shown to be a component of the 40 S “core”
hnRNP particle and has a role in cytoplasmic trafﬁcking of RNA [32].
As yet, it is not known whether or not hnRNP A3 may have a role in
telomere maintenance in vivo. In this work, we have examined the
telomeric DNA-binding activities of hnRNP A3 in vitro and in vivo, to
cast light on its biological functions.
2. Materials and methods
2.1. Media, enzymes, oligonucleotides, and antibodies
Dulbecco's modiﬁed Eagle's medium (DMEM), fetal bovine serum
(FBS), and antibiotics were from Gibco-BRL. Taq DNA polymerase was
from Abgene, Epsom, UK. All restriction enzymes were from New
England BioLab, Inc. Antibodies against hnRNP A2/B1 (sc-10035), Topo I
(sc-5342), TRF2 (sc-9143), RAP1 (sc-28197), and EGFP (sc-9996) were
purchased from Santa Cruz Biotech. Anti-TATA binding protein TBP
(ab818) and anti-TPP1 (ab39042) antibodies were obtained from
Abcam.Anti-FLAGantibodywas fromSigma. Polyclonal antibody against
hnRNP A3 was prepared by using oligopeptide VKPPPGRPQPDSFRC
(Genesis Biotech. Inc.). Gel electrophoresis reagents were from Bio-Rad.
All oligonucleotides were obtained from Bio Basic Inc.
2.2. Plasmids
The plasmids pEGFP-dA3 and pFLAG-dA3 were used to express
hnRNP dA3 containing N-terminal EGFP and FLAG tags, respectively.
The pEGFP-dA3 was constructed by subcloning the ApaI–BamHI
fragment from the pGEM-T/hnRNP A3 plasmid [20] into the pEGFP-C1
vector (BD Biosciences Clontech) at the ApaI–BamHI site. The plasmid
pFLAG-dA3 was constructed by subcloning the NdeI–NdeI fragment
from the pGEM-T/hnRNP A3 plasmid, into the pFLAG-CMV2 vector
(Sigma) at the EcoRV site. The pBabe-EGFP-dA3 plasmid, a retroviral
plasmid that expresses EGFP-dA3, was constructed by cloning the 1.7-
kb NheI–BamHI fragment, which contains the EGFP-dA3 gene from
pEGFP-dA3, into a high-titer retroviral vector pBabe-Puro.
The plasmids pET-15b/hnRNP A3 [20], pET-15b/dA3-M(RRM1),
pET-15b/dA3-M(RRM2) and pET-15b/dA3-M(RRM1,2) were used to
overexpress and isolate the dA3 and RNA-recognition motif (RRM)
mutants of dA3. The RRM mutant plasmids were constructed via site-
directed mutagenesis of pET-15b/hnRNP A3 DNA using QuikChange
Site-DirectedMutagenesis Kit (Stratagene). The sets of primers used for
PCR ampliﬁcation were: M(RRM1)S (5′-CCCAAACAAAACGTTCCA-
GAGGCGATGGTGATGTGACCTACTCTTGTGTTGAAG-3′) and M(RRM1)
AS (5 ′-CTTCAACACAAGAGTAGGTCACATCACCATCGCCTCTG-
GAACGTTTTGTTTGGG-3′) for pET-15b/dA3-M(RRM1); and M(RRM2)
S (5′-GACAGGCAGAGTGGGAAAAAGAGAGGAGATGCTGATGTAACTTTT-
GATGATCATGACA-3′) and M(RRM2)AS (5′-TGTCATGATCATCAAAAGT-
TACATCAGCATCTCCTCTCTTTTTCCCACTCTGCCTGTC-3′) for pET-15b/
dA3-M(RRM2). The plasmid pET-15b/dA3-M(RRM1,2) was con-
structed by using pET-15b/dA3-M(RRM1) as the template and M
(RRM2)S andM(RRM2)AS as the primer set to perform the site-directed
mutagenesis. All constructs were conﬁrmed by DNA sequencing.
The plasmids that express shRNA to knock-down hnRNP A3 were
constructed by inserting the following sequences into the pSUPER.
retro.puro (pSR) vector (OligoEngine, Inc.) following manufacturer's
suggestions. The selected shRNA sequences were:
pSR-A3(264-282): 5′-GGTGGATGCAGCAATGTGT-3′;
pSR-A3(323-341): 5′-AGAGAGCTGTTTCTAGAGA-3′;pSR-A3(687-705): 5′-CTTTGGAGGTGGTGGAGGT-3′;
and pSR-A3(966-984): 5′-CTATGGTGGTGGTGGGAAC-3′. The pSR-
Luc plasmid was constructed by inserting the 5′-CGTACGCGGAA-
TACTTCGA-3′ sequence, which targets ﬁreﬂy luciferasemRNA, into
the pSR vector.
2.3. Cell culture
Nasopharyngeal carcinoma-derived cell line NPC-TW02, human
oral squamous cancer cell line OEC-M1, human embryo kidney cell
line HEK293T, liver cancer cell line HepG2, and retrovirus packaging
cell line GP2-293 (BD Biosciences) were routinely cultured in DMEM
supplemented with 10% fetal bovine serum, 2mM L-glutamine, 100
U/ml penicillin, 100 U/ml streptomycin, and 0.25 μg/ml amphoter-
icin B. Cells were grown at 37 °C in a humidiﬁed incubator containing
5% CO2.
2.4. Retrovirus production and infection
To generate retroviral particles, GP2-293 packaging cells were
cotransfected with retroviral plasmid and pVSV-G plasmid (BD
Biosciences) by Arrest-In (Open Biosystems) according to manufac-
turer's instruction. After 16 h of transfection, medium containing the
transfection reagents were removed and replenished with fresh
media. After incubating for another 48 h, the media containing viral
particleswere centrifuged at 1250 rpm for 5 min, and the supernatants
were collected for the infection studies. Infection of cells with
retroviral particles was generally carried out in the presence of
polybrene at 8 μg/ml. Stable infected cells were obtained by culturing
the infected cells in the presence of puromycin at 0.4 μg/ml for 2-
3 weeks.
2.5. Nuclear extracts, protein puriﬁcation, and Western blot
Preparation of nuclear extracts, expression and puriﬁcation of
hnRNP dA3s, andWestern blot analyseswere performed as previously
described [20].
2.6. Electrophoresis mobility shift assay
The DNA-binding activity of puriﬁed proteins was assayed by
EMSA (electrophoresis mobility shift assay) as described previously
[20].
2.7. Immunoﬂurorescence confocal microscopy
EGFP-dA3 expressing cells were ﬁxed with 4% paraformadehyde in
a slide and permeabilized as described [33]. To detect telomeres in the
ﬁxed cells, the rabbit antibody against human TRF2, RAP1, or TPP1
was added to the cells and incubated for 1 h. After washing the cells
three times with phosphate buffer saline (PBS) containing 0.1% Triton
X-100, donkey anti-rabbit IgG antibody conjugated with red-
ﬂuorescent Alexa Fluor 594 dye (Invitrogen) was then added and
incubated for another 45 min at room temperature. Finally, the cells
were washed and coverslide was mounted onto the slide in
Vectashield mounting medium containing DAPI (Vector Laboratories,
H-100). Immunoﬂuorescence analyseswere performed by using 100×
objective lens at 0.4-μm intervals in an LSM 510 META confocal laser
scanning microscope (ZEISS).
2.8. Chromatin immunoprecipitation (ChIP) assay
Chromatin immunoprecipitation (ChIP) was performed in accor-
dance with the protocol for the ChIP assay kit (Upstate). In brief, cells
were suspended in DMEM containing 1% formaldehyde and incubated
at 25 °C for 10 min. The cross-linking reaction was stopped by adding
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by centrifugation. The conditions for preparing cell lysates, sonication
of DNA, and isolation of antibody-bound chromatin were as described
previously [33]. The antibody-bound chromatins were immunopre-
cipitated with anti-EGFP, anti-TRF2, or anti-FLAG antibody at 4 °C for
16 h. After reverse cross-linking, the DNAwas eluted, puriﬁed by ChIP
DNA Clean & Concentrator Kit (Zymo Research), and transferred to
immobilon-NY+membrane (Millipore) using theHYBRI-SLOTManifold
(WhatmanBiometra). Telomeric DNAwas detectedwith the TeloTAGGG
Telomere Length Assay kit (Roche). The presence of telomeric repeat
sequences in the immunoprecipitated DNA was also conﬁrmed by PCR
according to themethod described by Cawthon et al. [34]. Brieﬂy, 1 μl of
ChIPed DNA was placed in a buffer [75 mM Tris–HCl, pH 8.8, 1.5 mM
MgCl2, 0.01 % Tween 20, 20 mM (NH4)2SO4] containing 0.1 mM dNTP,
0.27 μM Tel1 primer (5′-GGTTTTTGAGGGTGAGGGTGAGGGTGAGGGT-
GAGGGT-3′), 0.9 μM Tel2 primer (5′-TCCCGACTATCCCTATCCCTATCCC-
TATCCCTATCCCTA-3′), and 2 units of Taq DNA polymerase. PCR
ampliﬁcation was carried out by 35 cycles of 95 °C for 15 s and 54 °C
for 2 min.2.9. Telomere length determination
The measurement of telomeric restriction fragment (TRF) length
was performed using TeloTAGGG Telomere Length Assay Kit (Roche)
by following the protocol provided by the manufacturer. In brief, 2 μg
of genomic DNA was digested with HinfI and RsaI, and the DNAFig. 1. Minimal binding sequence for hnRNP A3. (A) Schematic presentation of dA3 and th
puriﬁed through nickel column, and separated in a 12% polyacrylamide gel containing SDS (
brilliant blue (left) or by Western blot with antibody against His-tag (right). The molecular
(B) The oligonucleotides used for deducing the minimal binding sequence (MBS) for dA3. (C
and G2-1-1. The Tel-2 and NS oligonucleotides served as positive and negative controls, res
3.03 μM, respectively. (D) Same as in C, except oligonucleotides G2-1, 5′-G2-1, and int-G2-fragments were separated by electrophoresis on a 0.8% agarose gel.
The DNA in the gel was depurinated in 0.25 N HCl for 15 min,
denatured in 0.5 N NaOH, 1.5 M NaCl for 30 min, and then transferred
to immobilon-NY+ membrane (Millipore). After transfer, the DNA
was ﬁxed on the membrane by UV-cross-linking, pre-hybridized with
DIG Easy Hyb at 42 °C for 1 h, and then hybridized with telomere-
speciﬁc DIG-labeled probe at 42 °C for 3 h. The hybridized DNA was
washed with a buffer containing 0.3 M NaCl, 0.03 M sodium citrate,
and 0.1% SDS at room temperature and then with a buffer containing
30 mMNaCl, 3 mM sodium citrate, and 0.1% SDS at 50 °C. Detection of
the digoxigenin-labeled probes in the membrane was done by
exposure to Kodak X-ray ﬁlm using a DIG Luminescent Detection Kit
(Roche). The average length of TRF (L) was assessed by tracing with a
densitometer and calculated by the formula: L=Σ(ODi x Li)/ΣODi,
where ODi=integrated signal in interval i and Li=TRF length at the
midpoint of interval i.3. Results
3.1. The consensus and minimal binding sequence for hnRNP A3
As a prelude to further our understanding on the biological functions
of hnRNP A3, the DNA-binding properties of hnRNP A3 were ﬁrst
characterized in vitro. As noted in our previous study, stable clones
derived from the propagation of hnRNP A3-expressing plasmids in
Escherichia coli cells were deleted in nucleotides 735-974 of hnRNP A3e puriﬁed His-tag dA3. The His-tag dA3 protein was overexpressed in Escherichia coli,
SDS–PAGE). The proteins in the SDS–PAGE were identiﬁed by staining with Coomassie
mass markers (M) with the indicated mass in kilodaltons are shown in the left margin.
) EMSA was used to analyze the binding afﬁnity of dA3 for oligonucleotides G2-1, G2-2,
pectively. The concentrations of oligonucleotide and dA3 used in EMSA were 2 nM and
1 were used.
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245-335 in dA3, however, does not appear to inﬂuence the binding
afﬁnity to telomeric DNA. Here, we have employed puriﬁed dA3
(Fig. 1A) to determine the consensus andminimal binding sequences for
hnRNP A3.Fig. 2. Consensus binding sequence for hnRNP A3. The consensus sequence for hnRNP A3 bind
dA3 was mixed with biotinylated MBS-11mer probe in the presence of 800-fold excess com
mutations introduced at positions 2, 5, and 10 of the MBS-11mer were shown in panels A
concentrations of biotinylated MBS-11mer and dA3 used in EMSA were 8 nM and 6.06 μM, r
the same company but at different times.As shown previously, aminimal of two TTAGGG repeats is required
for the binding of dA3 to single-strand DNA [20]. To determine the
minimal binding sequence for dA3, the two TTAGGG repeats in the
oligonucleotides Tel-2 were modiﬁed either from the 5′ or 3′ end as
shown in Fig. 1B. A change of 5′ T to G (G2-1) did not affect its bindinging was deduced by competition analysis using the competitors listed in D. The puriﬁed
petitors and subjected to DNA-binding analysis using EMSA. The EMSA results for the
, B, and C, respectively. Summary of all results is shown in the right column of D. The
espectively. The two sets of competitors used in these experiments were obtained from
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of 3′ G to C (G2-1-1) greatly reduced the binding afﬁnity for dA3
(Fig. 1C). Therefore, the minimal binding sequence for dA3 appears to
consist of an undecamer TAGGGTTAGGG. To address the question
whether the minimal binding sequence has to be located at the 3′ end
of single-strand DNA, we compared the binding afﬁnity of dA3 for
DNA substrates that contain the TAGGGTTAGGG at the 5′ end or
internally. As shown in Fig. 1D, dA3 was capable to bind to all of the
DNA substrates, indicating that dA3 can bind to the TAGGGTTAGGG at
any location in single-strand DNA.
To determine the consensus sequence, the ability of various
11mers to compete for the binding of dA3 to biotinylated TAGGGT-
TAGGG was examined. Representative results are shown in Fig. 2A–C
for three sets of 11mers in which the nucleotide changes were made
at positions 2A, 5G, and 10G, respectively. As expected, it was evident
that the binding of dA3 to biotinylated TAGGGTTAGGG was competed
by the MBS-11mer but not the NS-11mer. While little or no
competition was observed by 11mers MBS-A2T, MBS-A2G, or MBS-
A2C (Fig. 2A), signiﬁcant competition was observed with the 11mers
MBS-G5A, MBS-G5T, or MBS-G5C (Fig. 2B). In the case of 11mers with
changes made at 10G position, while little or no competition was
observed for MBS-G10A or MBS-G10C, a small but consistent
competition was observed for MBS-G10T. This minor but consistentFig. 3.DNA-binding activity of hnRNP A3mutated in RRM1, RRM2, or both. (A) Schematic pre
are the conserved submotifs in RRM1 and RRM2. The amino acid sequence at the RNP-1 s o
mutants. (B–D) Recombinant dA3s with mutations inactivating RRM1 [M(RRM1)], RRM2 [M
by EMSA using 2 nM of biotinylated Tel-3 [(TTAGGG)3]. Coomassie blue staining of the inpu
protein.competition was scored as positive in this study, and the results of all
studies are summarized in Fig. 2D. Based on these results, we deduced
the consensus sequence for dA3 binding as: 5′-[T/C]AG[G/T]NN[T/C]
AG[G/T]N-3′, where N may be one of any four nucleotides.
3.2. RRM1 domain is critical for hnRNP A3 binding to telomeric DNA
Previous study has indicated that the RRM1 domain, but not RRM2,
of hnRNP A3 is sufﬁcient to confer speciﬁc binding to the telomeric
DNA [20]. To further address the role of RRM domains in the binding
afﬁnity to telomeric DNA, site-directed mutagenesis was used to
produce mutants of RRM1, RRM2, or RRM1,2 by mutating the two
conserved phenylalanine in the RNP-1 submotif to aspartic acid as
shown in Fig. 3A. The M(RRM1), M(RRM2), and M(RRM1,2) proteins
were isolated and their activity to bind telomeric DNA was examined
by EMSA. As shown in Fig. 3B–D, the ability to bind telomeric DNAwas
reduced for theM(RRM2) protein as comparedwith dA3 (Fig. 3D) and
was completely abolished in the M(RRM1) and M(RRM1,2) mutant
proteins (Figs. 3B and C). We noted, however, that the M(RRM2)-
containing proteins were relatively unstable and the puriﬁed
preparations always contained degradation products. Hence, higher
concentrations of M(RRM2)-containing proteins were required to
detect similar level of the 33-kDa intact protein as in the wild-typesentation of the structure of hnRNP A3 and its mutant derivatives. The RNP-1 and RNP-2
f RRM1 and RRM2 are shown for the wild-type, M(RRM1), M(RRM2), and M(RRM1, 2)
(RRM2)], and both RRM1&2 [M(RRM1,2)] were analyzed for their DNA-binding activity
t proteins is shown at the bottom panels. The arrowhead indicates the position of intact
Fig. 4.HnRNPA3associateswith telomeres in vivo. (A)Colocalizationof hnRNPA3with telomeremarkersTRF2, hRAP1, andTPP1 inNPC-TW02 cells. Cells expressingEGFP-taggedhnRNPA3
wereﬁxed in4% paraformaldehyde, stainedwith anti-TRF2 antibody (red, upperpanels), anti-hRAP1 antibody (red,middlepanels) or anti-TPP1 antibody (red, lower panels), and visualized
by confocal microscopy. Nuclei were visualized by DAPI (4′,6 diamidino-2-phenylindole) staining of chromosomal DNA. The merger of the red and green images yields yellow, which
indicates colocalization. (B) Analysis of telomere association by ChIP and slot-blot. Cells transfected with pFLAG-dA3 or vector (pFLAG-CMV2) were subjected to chromatin
immunoprecipitationwithantibodies speciﬁc for TRF2, FLAG, or EGFP. The immunoprecipitatedDNAwere slot-blotted for telomeresequences. Input represents 5%of total genomicDNA.The
DNAs immunoprecipitated by anti-TRF2 and anti-EGFP served as positive and negative controls, respectively. (C) PCR analysis of ChIPed DNA. TheDNAs immunoprecipitated from the cells
transfectedwithpFLAG-dA3were analyzed for thepresenceof telomeresequencebyPCR. Telomere fragments ampliﬁedbyPCR,whichmigratedasa ladder, aremarkedat the right. LaneN.C.
is a control with no DNA. Lane Input represents 5% of total genomic DNA.
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Fig. 5. Inhibition of hnRNP A3 expression by shRNAs in NPC-TW02 cells. Cells were tranfected with the indicated shRNA-expressing plasmid. After 96 h of transfection, cells were
collected and nuclear extracts were subjected to immunoblot with antibodies against hnRNP A3, hnRNP A2/B1, or Topo I, which serves as a loading control for nuclear protein. Mock
was treated with transfection reagent only.
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If the binding activity was compared at the similar levels of 33 kDa
intact protein, the M(RRM2) protein displayed only a moderate
deﬁciency in the binding afﬁnity as compared to dA3, suggesting that
the RRM2 domain is dispensable for the telomere-binding activity of
hnRNP A3. In addition, the binding activity of M(RRM2) was speciﬁc
to telomeric DNA since no detectable binding was observed when the
NS oligonucleotide was used as the binding substrate (data not
shown).Fig. 6. Effect of hnRNP A3 knock-down on telomere length of OEC-M1 cells. OEC-M1 cells s
10 days (A) or for an extended period up to about 52 population doublings (B). The nuclear e
panels). The genomic DNA was puriﬁed from OEC-M1 cells expressing each respective shR
blotting using the TeloTAGGG telomere length assay kit (bottom panels). Mean TRF length is
isolates. Lane M: molecular weight markers.3.3. Association of hnRNP A3 with telomere in vivo
To explore the telomere function of hnRNP A3 in vivo, we ﬁrst
addressed if hnRNP A3 may associate with telomere in vivo using
in situ immunostaining and ChIP analysis. For in situ immunostaining,
the colocalization of EGFP-tagged hnRNP A3 with telomere marker (e.
g., TRF2, RAP1, or TPP1) was examined by confocal microscopy. As
shown in Fig. 4A, although the majority of hnRNP A3 was found to
distribute diffusely in the nucleus, a portion of hnRNP A3was found totably expressing pSR-A3 (264-282), pSR-A3 (323-341), or pSR-Luc were cultivated for
xtracts were subjected to immunoblot with anti-hnRNP A3 and anti-TBP antibodies (top
NA, and the length of telomeric restriction fragment (TRF) was measured by Southern
indicated at the bottom of each lane. Lanes A and B in (A) were from two independent
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associated with telomere, we employed ChIP to analyze the presence
of telomeric sequence in the FLAG-dA3-immunoprecipitated chro-
matin DNAs. As shown in Figs. 4B and C, the DNA immunoprecipitated
by anti-FLAG from the pFLAG-dA3 transfected cells contained
telomeric sequence as evidenced by both slot-blot and PCR analyses.
3.4. Effect of hnRNP A3 knock-down and overexpression on telomere
length
To address if hnRNPA3may play a role in telomeremaintenance, we
examined the effects of hnRNP A3 knock-down and overexpression on
telomere length. For knocking-down hnRNP A3, four hnRNPA3-speciﬁc
RNAi sequenceswere cloned into pSR vector and tested for their speciﬁc
inhibitionof hnRNPA3expression.As shown in Fig. 5, pSR-A3 (268-282)
and pSR-A3 (323-341), but not pSR-A3 (687-705) or pSR-A3 (966-984),Fig. 7. Effect of EGFP-hnRNP A3 overexpression on telomere length of OEC-M1 cells. (A) The
panels) or EGFP-dA3 (lower panels) were examined by immunoﬂuorescence microscopy (ri
in the presence of puromycin. The TRF length of these DNAs was assayed by the TeloTAG
independent isolates. Mean TRF length is indicated at the bottom of each lane. Lane M: moeffectively inhibited the expression of hnRNP A3, but not hnRNP A2/B1
in NPC-TW02 cells. To avoid the off-target effects by RNAi, both pSR-A3
(268-282) and pSR-A3 (323-341) were used to prepare retroviral
particles for the infection of cells. The infected cells were cultivated in
the presence of puromycin, and their telomere lengths were deter-
mined. Initial studies were performed with the NPC-TW02 cells, and no
signiﬁcant changes in the TRF lengths were detected in the hnRNP A3
knock-down cells cultivated for 10 days (data not shown). However, the
average TRF in NPC-TW2was found to be very long (15 kb) and a small
change in the TRF lengths may not be readily detectable in our assay.
Therefore, an oral squamous cancer cell line OEC-M1 with a short TRF
(3.4 kb)wasused in the subsequent studies. OEC-M1cellswere infected
with pSR-A3 (268-282) and pSR-A3 (323-341), cultivated in the
presence of puromycin for 10 days, and their telomere lengths were
determined. As shown in Fig. 6A, pSR-A3 (268-282) and pSR-A3 (323-
341) effectively inhibited the expression of hnRNPA3, yet no signiﬁcantexpression of EGFP-containing protein in OEC-M1 cells stably expressing EGFP (upper
ght panels). (B) Genomic DNA was puriﬁed from the-infected cells cultured for 10 days
GG telomere length assay kit (Roche Applied Science). Lanes A and B were from two
lecular weight markers.
1172 P.-R. Huang et al. / Biochimica et Biophysica Acta 1803 (2010) 1164–1174change in TRF length was detected in the infected cells. Extended
cultivation of OEC-M1 cells under the knock-down condition for hnRNP
A3 also did not produce any signiﬁcant changes in the TRF lengths
(Fig. 6B). Therefore, knocking-down the expression of hnRNP A3 does
not appear to inﬂuence the telomere length maintenance.
Next, we asked if overexpression of hnRNP A3 may inﬂuence the
telomere length regulation. OEC-M1 cells were infected with pBabe-
EGFP or pBabe-EGFP-dA3, and the infected cells were cultivated for
10 days in the presence of puromycin. As shown in Fig. 7A, practically
all of the infected cells expressed EGFP or EGFP-dA3. Interestingly, The
TRF lengths were signiﬁcantly shorter in the OEC-M1 cells infected
with pBabe-EGFP-dA3 as compared with those infected with pBabe-
EGFP (Fig. 7B). To examine whether continued overexpression of dA3
may lead to even shorter TRF lengths, the infected cells were cultured
for an additional 72 population doublings in the absence of
puromycin. Under such culturing condition, the pBabe-EGFP-dA3-
infected cells continued to overexpress similar amounts of EGFP-dA3
(Fig. 8A) and continued to grow at a similar rate as the pBabe-EGFP-
infected cells (data not shown). Although the TRF lengths of the
pBabe-EGFP-dA3-infected cells at different population doublings
were shorter than the pBabe-EGFP-infected cells, prolonged cultiva-
tion of dA3-everexprssing OEC-M1 cells did not further shorten the
telomere length (Fig. 8B). We noted that the size of TRF in culture A of
OEC-M1/EGFP-dA3 at PD66 seems to be increasingwhen compared to
that of PD27. However, since similar effect was not observed in cultureFig. 8. Long-term effect of EGFP-hnRNP A3 overexpression on telomere length. (A) OEC-M
puromycin for 72 population doublings (PD). Nuclear extracts from cells at different PDs we
and B were from two independent cultures. The positions of endogenous hnRNP A3 and EGF
grown for 6 PD, 27 PD, or 66 PD and assayed for TRF length by the TeloTAGGG telomere lengt
TRF length is indicated at the bottom of each lane. Lane M: molecular weight markers.B of OEC-M1/EGFP-dA3, the signiﬁcance of TRF increase observed in
this particular sample is questionable.
4. Discussion
The hnRNPA/B proteins are among themost abundant RNA-binding
proteins, forming the core of the ribonucleoprotein complex that
associates with nascent transcripts in eukaryotic cells. The structural
diversity of these proteins generates a multitude of functions that
involve interactions with DNA or, more commonly, RNA. Compared to
the other members of hnRNP A/B family such as A1 and A2/B1, relative
little is known about the functions of hnRNP A3. In this work, we have
determined the minimal sequence for hnRNP A3 binding to DNA is an
undecamer containing the following consensus sequence 5′-[T/C]AG
[G/T]NN[T/C]AG[G/T]N-3′, which contains a double repeat of [T/C]AG
[G/T]N. The binding sequences for hnRNP A1 and hnRNP A2 are known
to contain double repeat of UAGGGA/U and GCCAA/G, respectively
[35,36]. Therefore, the preferred nucleic acid binding sequences for
hnRNP A/B proteins appear to contain a double repeat of 5-6
nucleotides. Comparison of the repeat sequences bound by hnRNP A/
B proteins reveal hnRNP A3 bears more resemblance to hnRNP A1, but
not to hnRNP A2, suggesting a functional redundancy may exist
between hnRNP A1 and A3.
The hnRNP A/B proteins are known to contain two RRM domains.
Biochemical studies of UP1 from hnRNP A1 have suggested that both1 cells stably expressing EGFP or EGFP-hnRNP A3 were cultivated in the absence of
re subjected to immunoblot with anti-EGFP, anti-hnRNP A3, and anti-TBP antibodies. A
P-hnRNP dA3 are indicated by arrowheads. (B) Genomic DNAs were puriﬁed from cells
h assay kit (Roche Applied Science). A and B were from two independent cultures. Mean
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[37]. We have shown previously that the RRM1 domain but not the
RRM2 domain of hnRNP A3 sufﬁces for the telomeric DNA-binding
activity [20]. Consistent with this notion, we demonstrated that the
ability tobind telomericDNAwas completely abolished in theM(RRM1)
and M(RRM1,2) mutant proteins but was only moderately reduced for
the M(RRM2) protein as compared to dA3 (Fig. 3), indicating that the
RRM1 but not the RRM2 domain is critical for the telomere-binding
activity of hnRNP A3. Our ﬁnding for a nonessential role of RRM2 in the
telomeric DNA-binding suggests that hnRNP A3 may employ a non-
dimeric mechanism to bind telomeric DNA.
Despite the fact that hnRNPs are among the ﬁrst identiﬁed proteins
that bind to single-stranded telomeric DNA [28], the biological function
of varioushnRNPs in telomeremaintenance remainspoorlyunderstood.
In thiswork,we have demonstrated that hnRNPA3was associatedwith
telomere as evidenced from both in situ immunostaining and ChIP
analyses (Fig. 4). Down-regulation of hnRNP A3, however, had no
detectable effect on cellular proliferation (data not shown) and
telomere length (Fig. 6). In contrast, overexpression of EGFP-dA3 was
found to produce a steady reduction of telomere lengths in OECM1 cells
(Figs. 7 and 8). Overexpression of EGFP-dA3 also produced a reduction
of telomere lengths in HepG2 cells, but not in NPC-076 and HEK293T
cells (datanot shown). Therefore, theeffect of hnRNPA3overexpression
on telomere length is detectable only in certain cell lines. At present, it is
not knownwhy some cell types are responsive to the effect of hnRNPA3
overexpression and some do not.We noted that the two responsive cell
lines (OEC-M1 and HepG2) have shorter TRF (3.4–3.9 kb), whereas the
NPC-076 and HEK293T cells have an average TRF of 15 and 11.7 kb,
respectively. Thus, it is possible that only the cells with short telomeres
are affected by the overexpression of hnRNP A3.
Our ﬁnding for a role of hnRNP A3 in telomere maintenance adds
another member to the growing list of hnRNPs known to participate
in telomere length regulation in vivo. The other members of hnRNP A/
B family, such as A1 and A2/B1, have been previously shown to bind
directly and speciﬁcally to single-stranded telomeric repeats in vitro
and associate with telomeres in vivo [21,22]. Although hnRNP A2 can
potentially interact with telomeric DNA and human telomerase RNA
simultaneously [22], there has been no report in the literature on its
involvement in telomere length regulation in vivo. The hnRNP A1 has
been shown to protect telomeric sequence from nuclease digestion
and inhibit telomerase extension in vitro [27]. Loss of hnRNP A1 in
mouse erythroleukemic cells is associated with short telomeres, and
restoring A1 expression increases the length of telomeres after
prolonged cell passages [30]. Ectopic expression of the proteolytic
fragment of hnRNP A1 (UP1) has been reported to promote an
increase of TRF length in HeLa cells [30]. Therefore, the results from
cellular studies seem to suggest for a positive role of hnRNP A1 in
telomere length regulation. Our ﬁnding for the production of steady-
state short telomeres in OEC-M1 cells overexpressing EGFP-dA3, on
the other hand, suggests that hnRNP A3 acts as a negative regulator of
telomere length maintenance in vivo. It is puzzling why the two
structurally similar hnRNP A1 and hnRNP A3 would appear to exert
opposite effects on telomere length regulation. One possible expla-
nation is that the binding of hnRNP A1 to G-rich single-stranded
telomeric DNA may facilitate the recruitment of telomerase to
telomere, while the binding of hnRNP A3 to G-rich single-stranded
overhang only inhibits telomerase extension as observed in vitro [20].
It should be pointed out that many of the hnRNPs, including hnRNP
A3, are TERRA RNA-binding proteins [38] and thus may be involved in
cis-based mechanisms of telomeric chromatin organization and main-
tenance [6,7]. In view of the fact that many hnRNPs are capable of
binding to single-stranded telomeric DNA and to TERRA RNA, it would
not be surprising that more hnRNPs are found to involve in telomere
maintenance. The future challenges, therefore, are to understand the
functional overlap and/or antagonism of these hnRNPs in telomere
maintenance.Acknowledgments
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